SIOUX FALLS, S.D. (AP) — South Dakota resumes using Johnson & Johnson’s COVID-19 vaccinations.
U.S. health officials had lifted a pause on using J&J’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot. The government had uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot out of nearly 8 million people given the J&J shot. All were women, most under age 50. Three died, and seven remain hospitalized.
The South Dakota Department of Health says no serious reactions have been reported among over 16,000 South Dakotans who received the vaccine.
